TM

Tangirala Murali Kumar

Director DIN 06688737
DIN 06688737 First appointment Nov 2013
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Tangirala Murali Kumar

Data last updated:

Tangirala Murali Kumar was a Director at Sls Reagents Private Limited (from 2013) and Director at Sls Pharmaceuticals Private Limited (from 2014).

DIN 06688737
First Appointment 21 Nov 2013
Oldest Company Age 13 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sls Reagents Private Limited U24233TG2013PTC091158
Director21 Nov 20132013₹2.44 Cr (FY 2018)Strike Off
Sls Pharmaceuticals Private Limited U24232TG2013PTC087974
Director10 May 20142013₹4.30 Cr (FY 2018)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sls Reagents Private Limited
Sls Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Tangirala Murali Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tangirala Murali Kumar

Tangirala Murali Kumar was first appointed on 21 Nov 2013 as Director at Sls Reagents Private Limited. The most recent appointment on record is 10 May 2014 at Sls Pharmaceuticals Private Limited.

Tangirala Murali Kumar held 2 earlier board appointments: Sls Reagents Private Limited (Director, from 21 Nov 2013); Sls Pharmaceuticals Private Limited (Director, from 10 May 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available